The drug firm reported over two-fold increase in its net profit at Rs 92.7 crore for the fourth quarter ended December 31, 2013.
Reacting to the good numbers, shares of the company opened on a bullish note and jumped 5.25 per cent to an intra-day high of Rs 2,779 on the BSE.
At the end of today's trading session the stock was quoted at Rs 2,728.40, higher by 3.34 per cent over its previous closing price. Accordingly the market worth of the company increased by Rs 268 crore to Rs 6,283 crore.
"Sanofi India posted numbers better than expected," Angel Broking (VP-Research, Pharma) Sarabjit Kour Nangra said, adding that "the main surprise came in at operating front."
The company while announcing the earnings yesterday, said that the "significantly better export performance during the quarter and the year ended December 31, 2013, has resulted in improvement in profitability of the company."